The CXCR4 Antagonist, AMD3100, Reverses Mesenchymal Stem Cell-Mediated Drug Resistance in Relapsed/Refractory Acute Lymphoblastic Leukemia

The CXCR4 Antagonist, AMD3100, Reverses Mesenchymal Stem Cell-Mediated Drug Resistance in Relapsed/Refractory Acute Lymphoblastic Leukemia

Shan Wang, Xiaojiao Wang, Sha Liu, Shengnan Zhang, Xudong Wei, Yongping Song, Qingsong Yin Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital), Zhengzhou, People’s Republic of ChinaCorrespondence: Yongping Song; Qingsong Yin Email songyo...

Full description

Bibliographic Details
Main Authors: Wang S, Wang X, Liu S, Zhang S, Wei X, Song Y, Yin Q
Format: Article
Language:English
Published: Dove Medical Press 2020-07-01
Series:OncoTargets and Therapy
Subjects:
acute lymphoblastic leukemia
relapsed/refractory
cxcr4/cxcl12 signaling
bone marrow microenvironment
drug resistance
Online Access:https://www.dovepress.com/the-cxcr4-antagonist-amd3100-reverses-mesenchymal-stem-cell-mediated-d-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/the-cxcr4-antagonist-amd3100-reverses-mesenchymal-stem-cell-mediated-d-peer-reviewed-article-OTT

Similar Items